The Diabetes Remission in India (DiRemI) study: Protocol for a prospective matched-control trial
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306394 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Pramod Tripathi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Freedom From Diabetes Research Foundation, Pune, Maharashtra, India. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The global rise in diabetes, particularly in India, poses a significant public health challenge, with factors such as limited awareness, financial strain, and cultural considerations hindering its effective management. Although lifestyle changes have shown promising results, their consistent implementation and maintenance continue to pose challenges. Most studies have focused primarily on dietary modifications, overlooking other essential aspects of lifestyle intervention. The DiRemI study aims to address these gaps by evaluating the efficacy of a comprehensive one-year program that combines diet, exercise, psychological support, and medical management to achieve weight loss, diabetes remission, and improved glycemic control among patients with type 2 diabetes (T2D) in India, while also considering the unique needs of the Indian population.
Methods
The DiRemI study is a prospective, open-label, matched-group trial aimed at assessing the impact of a one-year online integrated intensive lifestyle intervention (ILI) comprising dietary modifications, physical activity, psychological support, and medical management on weight loss and remission in adult T2D patients (aged 30–70 years), with a body mass index (BMI) between 25 and 35 kg/m 2 , and disease duration of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Research, Freedom From Diabetes Research Foundation, Pune, Maharashtra, India.
- Department of Management & Exercise Science, Freedom from Diabetes Clinic, Pune, Maharashtra, India.
- Department of Medicine, Dia Care- Diabetes Care and Hormone Clinic, Diabetology, Ahmedabad, Gujarat, India.
ORCID-Profile: Nidhi Kadam
Zitieren
APA
Tripathi, P., Kadam, N., Tiwari, D., Kathrikolly, T., Vyawahare, A., Sharma, B., Ganla, M., & Saboo, B. (2024). The Diabetes Remission in India (DiRemI) study: Protocol for a prospective matched-control trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0306394
Vancouver
Tripathi P, Kadam N, Tiwari D, Kathrikolly T, Vyawahare A, Sharma B, et al. The Diabetes Remission in India (DiRemI) study: Protocol for a prospective matched-control trial. PLOS ONE. 2024. doi:10.1371/journal.pone.0306394
BibTeX
@article{Tripathi2024,
author = {Tripathi, Pramod and Kadam, Nidhi and Tiwari, Diptika and Kathrikolly, Thejas and Vyawahare, Anagha and Sharma, Baby and Ganla, Malhar and Saboo, Banshi},
title = {The Diabetes Remission in India (DiRemI) study: Protocol for a prospective matched-control trial},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306394}
}
EUVIMED